This indicator includes the count and rate of newly diagnosed cases of Hepatitis C per 1,000 individuals estimated to have Drug Use Disorder.

Mean Length of Stay (LOS) for all Pennsylvania general acute care hospital stays for newborns, categorized by the presence or absence of Neonatal Abstinence Syndrome (NAS).
Neonatal Abstinence Syndrome, or neonatal drug withdrawal, is an array of problems that develops shortly after birth in newborns who were exposed to addictive drugs, most often opioids, while in the mother’s womb. Withdrawal signs develop because these newborns are no longer exposed to the drug for which they have become physically dependent.
This analysis is restricted to newborns with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals. Additionally, hospital stays with rehabilitation revenue codes and hospital stays that ended in a transfer or mortality were excluded.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This dataset contains the count of individuals with Medical Assistance coverage (MA) receiving any form of MAT (Medication-Assisted treatment) by case county. The counts cover calendar years 2015 - 2018. If a count field is null, then the count is suppressed due to low numbers. If the county is null, then the county is unknown.

Percent of Pennsylvania newborn hospital stays, categorized by the presence or absence of Neonatal Abstinence Syndrome (NAS), with Medicaid as the Anticipated Primary Payer.
Neonatal Abstinence Syndrome, or neonatal drug withdrawal, is an array of problems that develops shortly after birth in newborns who were exposed to addictive drugs, most often opioids, while in the mother’s womb. Withdrawal signs develop because these newborns are no longer exposed to the drug for which they have become physically dependent.
This analysis is restricted to newborns with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

Percent of Pennsylvania delivery hospital stays, categorized by the presence or absence of opioid use, that had at least one readmission within 365 of being discharged.

Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.

This analysis is restricted to delivery hospital stays with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.

PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

Countywide counts of maternal hospital stays with opioid use and countywide rates of maternal hospital stays with opioid use per 1,000 maternal stays.
Maternal stays include those involving a delivery, as well as other pregnancy-related stays. Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.
This analysis is restricted to maternal hospital stays for Pennsylvania-state residents who were hospitalized in Pennsylvania hospitals.
Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This indicator includes the rate of hospitalization per 1,000 individuals estimated to have Opioid Use Disorder (OUD) for Opioid Use Disorder, Intracranial and intraspinal Abscess, Osteomyelitis, Endocarditis, Soft skin tissue infection, and Viral Hepatitis (B, C, and D) for individuals diagnosed with OUD in the same calendar year.
* Analyses were completed by the University of Pittsburgh using data from the PA Health Care Cost Containment Council and in cooperation with PA DOH.
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.

This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

This dataset summarizes the number of women on Medical Assistance (MA) ages 12 to 55 years old with a delivery and indicates how many of those women were diagnosed with Opioid Use Disorder (OUD) during their pregnancy. Delivery includes live birth or stillbirth. Data collection started in 2016 and will be updated quarterly as data becomes available.

This interactive map depicts the amount of opioids, in kilograms, seized by the Pennsylvania State Police quarterly, by county. Use the drop-down menus to select quarter and year to see the amount of opioids seized by the Pennsylvania State Police in each county. The drug drop-down menu will allow you to view a separate map for each opioid drug type. Care should be taken regarding inferences made about the location in which opioids are seized as drugs can be transient and therefore seized in areas other than their origination or destination. The opioid seizures reflected on this map may not include all active investigations by the Pennsylvania State Police.